Global Intracranial Hemorrhage Diagnosis & Treatment Market By Based on Type (Epidural Hematoma, Subdural Hematoma), By Based on Diagnosis & Treatment (Diagnosis, Treatment) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Intracranial Hemorrhage Diagnosis & Treatment Market Introduction

Bleeding in or around the brain due to a burst artery is known as a brain hemorrhage. It’s a certain type of stroke. A brain hemorrhage is often classified based on where it occurs in the brain. An intracranial hemorrhage is a type of bleeding that occurs anywhere inside the skull. When a blood artery within the skull ruptures or leaks, it causes intracranial hemorrhage, also known as intracranial bleed. It can result from physical trauma or non-traumatic causes such as a ruptured aneurysm. Anticoagulant therapy, as well as blood coagulation abnormalities, can increase the risk of an intracranial hemorrhage. Hypertension is the cause of more than half of all intracranial hemorrhages.

Subtypes of Intracranial hemorrhage are intracerebral hemorrhage, subarachnoid bleeds, epidural bleeds, and subdural bleeds. An intracerebral hemorrhage is a type of bleeding that occurs within the brain. A subarachnoid hemorrhage is a type of bleeding that occurs between the brain’s covering and the brain tissue itself. A subdural or epidural hematoma occurs when a blood clot forms between the skull and the brain, depending on whether it is below or above the brain’s protective covering (dura). A traumatic brain injury or a fall is the most common cause of subdural and epidural hematomas.

Intracranial bleeding is a serious medical emergency because the accumulation of blood within the skull can cause an increase in intracranial pressure, potentially crushing fragile brain tissue or limiting blood supply. Severe increases in Intracranial Pressure (ICP) can cause brain herniation, in which parts of the brain are squeezed past structures in the skull.

Detailed Segmentation

The global intracranial hemorrhage diagnosis & treatment market is segmented on the basis of – Type, Diagnosis & Treatment, and Region.

Based on Type

• Intracerebral Hemorrhage
• Subarachnoid Hemorrhage
• Epidural Hematoma
• Subdural Hematoma

Based on Diagnosis & Treatment

• Diagnosis
  • CT
  • MRI
  • Others
• Treatment
  • Medication
    • Anti-Hypertensive Drugs
    • Coagulants
    • Others
  • Surgery
    • Decompression Surgery
    • Craniotomy with Open Surgery
    • Endoscopic Evacuation
    • Stereotactic Aspiration
    • Clipping or Coiling Procedures

Based on Regions

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics

Intracranial hemorrhage diagnosis and therapy is currently a highly profitable commercial opportunity because of the vast number of hypertension patients, as well as the potential of increasing research efforts concerning potential therapeutic molecules. Furthermore, technical advancements such as point-of-care drug delivery systems, together with a growing focus on maintaining a superior quality of life, are elements that are contributing to this market’s revenue growth trajectory. Another factor contributing to this market’s further expansion is the increasing incidence of traumatic injury patients.

The intrusive nature of most intracranial pressure monitors is a key market limitation, posing a threat to greater market expansion prospects. However, this industry is expected to grow rapidly in the near future due to the increasing number of cerebral hemorrhage patients, and a high adoption rate for novel therapeutics.

Intracranial Hemorrhage Diagnosis & Treatment Market Top Key Players:

• Canon Inc.
• FUJIFILM Holdings Corporation
• GE Healthcare
• Hitachi Ltd.
• Infrascan Inc.
• Johnson & Johnson
• Koninklijke Philips N.V.
• Medtronic PLC
• Siemens AG
• Stryker Corporation
• Other Key Players

Key Developments

Fujifilm’s Reili® artificial intelligence technology is now being used in clinical trials to identify and diagnose intracranial hemorrhage and breast cancer.